Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Current Assets (2020 - 2025)

Journey Medical (DERM) has disclosed Current Assets for 6 consecutive years, with $56.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets rose 22.15% year-over-year to $56.4 million, compared with a TTM value of $56.4 million through Sep 2025, up 22.15%, and an annual FY2024 reading of $48.2 million, down 14.66% over the prior year.
  • Current Assets was $56.4 million for Q3 2025 at Journey Medical, up from $51.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $90.3 million in Q1 2022 and bottomed at $44.7 million in Q3 2023.
  • Average Current Assets over 5 years is $61.3 million, with a median of $56.4 million recorded in 2025.
  • The sharpest move saw Current Assets surged 139.75% in 2021, then tumbled 43.86% in 2023.
  • Year by year, Current Assets stood at $84.5 million in 2021, then dropped by 8.06% to $77.7 million in 2022, then dropped by 27.32% to $56.5 million in 2023, then decreased by 14.66% to $48.2 million in 2024, then rose by 17.04% to $56.4 million in 2025.
  • Business Quant data shows Current Assets for DERM at $56.4 million in Q3 2025, $51.3 million in Q2 2025, and $54.0 million in Q1 2025.